Cargando…

Persistent opioid use and opioid-related harm after hospital admissions for surgery and trauma in New Zealand: a population-based cohort study

INTRODUCTION: Opioid use has increased globally for the management of chronic non-cancer-related pain. There are concerns regarding the misuse of opioids leading to persistent opioid use and subsequent hospitalisation and deaths in developed countries. Hospital admissions related to surgery or traum...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Jiayi, Merry, Alan Forbes, Beyene, Kebede A, Campbell, Doug, Frampton, Chris, Jones, Peter, McCall, John, Moore, Matthew, Chan, Amy Hai Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817825/
https://www.ncbi.nlm.nih.gov/pubmed/33468530
http://dx.doi.org/10.1136/bmjopen-2020-044493
_version_ 1783638715173699584
author Gong, Jiayi
Merry, Alan Forbes
Beyene, Kebede A
Campbell, Doug
Frampton, Chris
Jones, Peter
McCall, John
Moore, Matthew
Chan, Amy Hai Yan
author_facet Gong, Jiayi
Merry, Alan Forbes
Beyene, Kebede A
Campbell, Doug
Frampton, Chris
Jones, Peter
McCall, John
Moore, Matthew
Chan, Amy Hai Yan
author_sort Gong, Jiayi
collection PubMed
description INTRODUCTION: Opioid use has increased globally for the management of chronic non-cancer-related pain. There are concerns regarding the misuse of opioids leading to persistent opioid use and subsequent hospitalisation and deaths in developed countries. Hospital admissions related to surgery or trauma have been identified as contributing to the increasing opioid use internationally. There are minimal data on persistent opioid use and opioid-related harm in New Zealand (NZ), and how hospital admission for surgery or trauma contributes to this. We aim to describe rates and identify predictors of persistent opioid use among opioid-naïve individuals following hospital discharge for surgery or trauma. METHODS AND ANALYSIS: This is a population-based, retrospective cohort study using linked data from national health administrative databases for opioid-naïve patients who have had surgery or trauma in NZ between January 2006 and December 2019. Linked data will be used to identify variables of interest including all types of hospital surgeries in NZ, all trauma hospital admissions, opioid dispensing, comorbidities and sociodemographic variables. The primary outcome of this study will be the prevalence of persistent opioid use. Secondary outcomes will include mortality, opioid-related harms and hospitalisation. We will compare the secondary outcomes between persistent and non-persistent opioid user groups. To compute rates, we will divide the total number of outcome events by total follow-up time. Multivariable logistic regression will be used to identify predictors of persistent opioid use. Multivariable Cox regression models will be used to estimate the risk of opioid-related harms and hospitalisation as well as all-cause mortality among the study cohort in a year following hospital discharge for surgery or trauma. ETHICS AND DISSEMINATION: This study has been approved by the Auckland Health Research Ethics Committee (AHREC- AH1159). Results will be reported in accordance with the Reporting of studies Conducted using Observational Routinely collected health data statement (RECORD).
format Online
Article
Text
id pubmed-7817825
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-78178252021-01-28 Persistent opioid use and opioid-related harm after hospital admissions for surgery and trauma in New Zealand: a population-based cohort study Gong, Jiayi Merry, Alan Forbes Beyene, Kebede A Campbell, Doug Frampton, Chris Jones, Peter McCall, John Moore, Matthew Chan, Amy Hai Yan BMJ Open Epidemiology INTRODUCTION: Opioid use has increased globally for the management of chronic non-cancer-related pain. There are concerns regarding the misuse of opioids leading to persistent opioid use and subsequent hospitalisation and deaths in developed countries. Hospital admissions related to surgery or trauma have been identified as contributing to the increasing opioid use internationally. There are minimal data on persistent opioid use and opioid-related harm in New Zealand (NZ), and how hospital admission for surgery or trauma contributes to this. We aim to describe rates and identify predictors of persistent opioid use among opioid-naïve individuals following hospital discharge for surgery or trauma. METHODS AND ANALYSIS: This is a population-based, retrospective cohort study using linked data from national health administrative databases for opioid-naïve patients who have had surgery or trauma in NZ between January 2006 and December 2019. Linked data will be used to identify variables of interest including all types of hospital surgeries in NZ, all trauma hospital admissions, opioid dispensing, comorbidities and sociodemographic variables. The primary outcome of this study will be the prevalence of persistent opioid use. Secondary outcomes will include mortality, opioid-related harms and hospitalisation. We will compare the secondary outcomes between persistent and non-persistent opioid user groups. To compute rates, we will divide the total number of outcome events by total follow-up time. Multivariable logistic regression will be used to identify predictors of persistent opioid use. Multivariable Cox regression models will be used to estimate the risk of opioid-related harms and hospitalisation as well as all-cause mortality among the study cohort in a year following hospital discharge for surgery or trauma. ETHICS AND DISSEMINATION: This study has been approved by the Auckland Health Research Ethics Committee (AHREC- AH1159). Results will be reported in accordance with the Reporting of studies Conducted using Observational Routinely collected health data statement (RECORD). BMJ Publishing Group 2021-01-19 /pmc/articles/PMC7817825/ /pubmed/33468530 http://dx.doi.org/10.1136/bmjopen-2020-044493 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Epidemiology
Gong, Jiayi
Merry, Alan Forbes
Beyene, Kebede A
Campbell, Doug
Frampton, Chris
Jones, Peter
McCall, John
Moore, Matthew
Chan, Amy Hai Yan
Persistent opioid use and opioid-related harm after hospital admissions for surgery and trauma in New Zealand: a population-based cohort study
title Persistent opioid use and opioid-related harm after hospital admissions for surgery and trauma in New Zealand: a population-based cohort study
title_full Persistent opioid use and opioid-related harm after hospital admissions for surgery and trauma in New Zealand: a population-based cohort study
title_fullStr Persistent opioid use and opioid-related harm after hospital admissions for surgery and trauma in New Zealand: a population-based cohort study
title_full_unstemmed Persistent opioid use and opioid-related harm after hospital admissions for surgery and trauma in New Zealand: a population-based cohort study
title_short Persistent opioid use and opioid-related harm after hospital admissions for surgery and trauma in New Zealand: a population-based cohort study
title_sort persistent opioid use and opioid-related harm after hospital admissions for surgery and trauma in new zealand: a population-based cohort study
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817825/
https://www.ncbi.nlm.nih.gov/pubmed/33468530
http://dx.doi.org/10.1136/bmjopen-2020-044493
work_keys_str_mv AT gongjiayi persistentopioiduseandopioidrelatedharmafterhospitaladmissionsforsurgeryandtraumainnewzealandapopulationbasedcohortstudy
AT merryalanforbes persistentopioiduseandopioidrelatedharmafterhospitaladmissionsforsurgeryandtraumainnewzealandapopulationbasedcohortstudy
AT beyenekebedea persistentopioiduseandopioidrelatedharmafterhospitaladmissionsforsurgeryandtraumainnewzealandapopulationbasedcohortstudy
AT campbelldoug persistentopioiduseandopioidrelatedharmafterhospitaladmissionsforsurgeryandtraumainnewzealandapopulationbasedcohortstudy
AT framptonchris persistentopioiduseandopioidrelatedharmafterhospitaladmissionsforsurgeryandtraumainnewzealandapopulationbasedcohortstudy
AT jonespeter persistentopioiduseandopioidrelatedharmafterhospitaladmissionsforsurgeryandtraumainnewzealandapopulationbasedcohortstudy
AT mccalljohn persistentopioiduseandopioidrelatedharmafterhospitaladmissionsforsurgeryandtraumainnewzealandapopulationbasedcohortstudy
AT moorematthew persistentopioiduseandopioidrelatedharmafterhospitaladmissionsforsurgeryandtraumainnewzealandapopulationbasedcohortstudy
AT chanamyhaiyan persistentopioiduseandopioidrelatedharmafterhospitaladmissionsforsurgeryandtraumainnewzealandapopulationbasedcohortstudy